Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment

The 2019 novel coronavirus disease (COVID-19) has lasted for over 3 years and has seriously affected the regular life trajectory of human beings. The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has caused non-negligible harm to people’s respiratory systems and multiple organs. Altho...

Full description

Bibliographic Details
Main Authors: Yuyin Fang, Peizhen Lao, Longqian Tang, Jingyi Chen, Yuxi Chen, Lei Sun, Wenwen Tan, Xingliang Fan
Format: Article
Language:English
Published: SAGE Publishing 2023-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/09636897231184611
_version_ 1797788586686283776
author Yuyin Fang
Peizhen Lao
Longqian Tang
Jingyi Chen
Yuxi Chen
Lei Sun
Wenwen Tan
Xingliang Fan
author_facet Yuyin Fang
Peizhen Lao
Longqian Tang
Jingyi Chen
Yuxi Chen
Lei Sun
Wenwen Tan
Xingliang Fan
author_sort Yuyin Fang
collection DOAJ
description The 2019 novel coronavirus disease (COVID-19) has lasted for over 3 years and has seriously affected the regular life trajectory of human beings. The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has caused non-negligible harm to people’s respiratory systems and multiple organs. Although the pathogenesis of COVID-19 has been fully elucidated, there is still a lack of effective and specific treatment for COVID-19. Mesenchymal stem cells (MSCs) or MSC-derived extracellular vesicles (MSC-EVs) by far have become the most promising candidates in preclinical studies and clinical trials, and MSC-related therapies have shown their potential to treat severe COVID-19. The multidirectional differentiation potential and immunomodulatory function of MSCs have allowed the cells to exert multiple cellular and molecular actions on different immune cells and organs. It is critical to understand the therapeutic roles of MSCs before entering the clinics for COVID-19 and other diseases. This review summarizes the recent progress of particular mechanisms underlying the immunomodulatory and tissue regenerative effects of MSCs toward COVID-19. We focused on discussing the functional roles of MSC-mediated effects on immune cell responses, cell survival, and organ regeneration. Besides, the novel discoveries and recent findings of MSC clinical application in patients with COVID-19 were highlighted. This will provide an overview of the current research on the rapid development of MSC-based therapies not only for COVID-19 but also for other immune-mediated/immune-dysregulating diseases.
first_indexed 2024-03-13T01:37:41Z
format Article
id doaj.art-3f615ee67bdd4f59aa42494268c5b982
institution Directory Open Access Journal
issn 1555-3892
language English
last_indexed 2024-03-13T01:37:41Z
publishDate 2023-07-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-3f615ee67bdd4f59aa42494268c5b9822023-07-03T19:33:58ZengSAGE PublishingCell Transplantation1555-38922023-07-013210.1177/09636897231184611Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 TreatmentYuyin Fang0Peizhen Lao1Longqian Tang2Jingyi Chen3Yuxi Chen4Lei Sun5Wenwen Tan6Xingliang Fan7Institute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaInstitute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaInstitute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaInstitute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaInstitute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaInstitute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaInstitute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaInstitute of Biological and Food Engineering, Guangdong University of Education, Guangzhou, P.R. ChinaThe 2019 novel coronavirus disease (COVID-19) has lasted for over 3 years and has seriously affected the regular life trajectory of human beings. The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) has caused non-negligible harm to people’s respiratory systems and multiple organs. Although the pathogenesis of COVID-19 has been fully elucidated, there is still a lack of effective and specific treatment for COVID-19. Mesenchymal stem cells (MSCs) or MSC-derived extracellular vesicles (MSC-EVs) by far have become the most promising candidates in preclinical studies and clinical trials, and MSC-related therapies have shown their potential to treat severe COVID-19. The multidirectional differentiation potential and immunomodulatory function of MSCs have allowed the cells to exert multiple cellular and molecular actions on different immune cells and organs. It is critical to understand the therapeutic roles of MSCs before entering the clinics for COVID-19 and other diseases. This review summarizes the recent progress of particular mechanisms underlying the immunomodulatory and tissue regenerative effects of MSCs toward COVID-19. We focused on discussing the functional roles of MSC-mediated effects on immune cell responses, cell survival, and organ regeneration. Besides, the novel discoveries and recent findings of MSC clinical application in patients with COVID-19 were highlighted. This will provide an overview of the current research on the rapid development of MSC-based therapies not only for COVID-19 but also for other immune-mediated/immune-dysregulating diseases.https://doi.org/10.1177/09636897231184611
spellingShingle Yuyin Fang
Peizhen Lao
Longqian Tang
Jingyi Chen
Yuxi Chen
Lei Sun
Wenwen Tan
Xingliang Fan
Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
Cell Transplantation
title Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
title_full Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
title_fullStr Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
title_full_unstemmed Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
title_short Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
title_sort mechanisms of potential therapeutic utilization of mesenchymal stem cells in covid 19 treatment
url https://doi.org/10.1177/09636897231184611
work_keys_str_mv AT yuyinfang mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment
AT peizhenlao mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment
AT longqiantang mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment
AT jingyichen mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment
AT yuxichen mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment
AT leisun mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment
AT wenwentan mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment
AT xingliangfan mechanismsofpotentialtherapeuticutilizationofmesenchymalstemcellsincovid19treatment